The document outlines microbial limit tests for assessing the microbiological quality of non-sterile pharmaceutical and cosmetic products, detailing methods to estimate total viable counts and detect specific pathogens like E. coli, Salmonella, S. aureus, and P. aeruginosa. It also describes testing procedures including sample preparation, incubation, and cultivation on selective media, along with requirements for confirming the presence of harmful microorganisms. The document emphasizes the importance of ensuring products are free from specific pathogens to prevent infections and ensure safety in pharmaceutical formulations.